MARY LUMLEY: Open Payments
NPI 1093329633 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 14 payments from 5 companies in 2025. Trend: 2023 $36 · 2024 $233 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $158 |
| ABBVIE INC. | 2 | $28 |
| Lilly USA, LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: CAPLYTA, ZEPBOUND, Auvelity, Adempas, VRAYLAR, QULIPTA.
Industry payments across MS — which companies pay providers there.
